Literature DB >> 375940

Circulating immune complexes in mixed connective tissue disease.

J T Halla, J E Volanakis, R E Schrohenloher.   

Abstract

Circulating immune complexes were measured by three assays (monoclonal rheumatoid factor radioimmunoassay, C1q-binding assay, Raji cell radioassay) in sera from patients with mixed connective tissue disease. Evidence for circulating immune complexes was found by at least one method in 94% of sera. The highest frequency of positive results was noted by the Raji cell radioassay (88%). However, a significant number of patients also had immune complexes measured by the C1q-binding assay (50%) and monoclonal rheumatoid factor radioimmunoassay (45%). Further, the levels of immune complexes are measured by the Raji cell radioassay, and to a lesser extent the C1q-binding assay, correlated with disease activity and represent a potentially useful clinical tool. The pattern of reactivity in mixed connective tissue disease sera differed from rheumatoid arthritis, scleroderma, and polymyositis. This suggests that a spectrum of immune complexes is found in these rheumatic diseases and supports the concept that mixed connective tissue disease is distinct from these diseases.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 375940     DOI: 10.1002/art.1780220507

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  8 in total

Review 1.  Immune complexes in human diseases: a review.

Authors:  A N Theofilopoulos; F J Dixon
Journal:  Am J Pathol       Date:  1980-08       Impact factor: 4.307

2.  Interpretation of the Raji cell assay in sera containing anti-nuclear antibodies and immune complexes.

Authors:  A C Horsfall; P J Venables; P A Mumford; R N Maini
Journal:  Clin Exp Immunol       Date:  1981-05       Impact factor: 4.330

Review 3.  Circulating immune complexes in dermatologic disease.

Authors:  T J Lawley; R P Hall
Journal:  Springer Semin Immunopathol       Date:  1981

4.  Soluble immune complexes in patients with diabetes mellitus: detection and pathological significance.

Authors:  G Virella; H Wohltmann; J Sagel; M F Lopes-Virella; M Kilpatrick; C Phillips; J Colwell
Journal:  Diabetologia       Date:  1981-09       Impact factor: 10.122

5.  Detection of immune complexes and their relationship to rheumatoid factor in a variety of autoimmune disorders.

Authors:  R M Pope; S Yoshinoya; S J McDuffy
Journal:  Clin Exp Immunol       Date:  1981-11       Impact factor: 4.330

6.  Clinical significance of U1-RNP immune complexes in mixed connective tissue disease and systemic lupus erythematosus.

Authors:  N Negoro; Y Kanayama; T Takeda; K Amatsu; S Koda; Y Inoue; T Kim; M Okamura; T Inoue
Journal:  Rheumatol Int       Date:  1987       Impact factor: 2.631

7.  Clinical profiles of patients with antibodies to nuclear ribonucleoprotein.

Authors:  J Calderon; V Rodriguez-Valverde; S Sanchez Andrade; J L Riestra; J Gomez-Reyno
Journal:  Clin Rheumatol       Date:  1984-12       Impact factor: 2.980

8.  Nailfold capillaroscopy changes associated with anti-RNP antibodies in systemic lupus erythematosus.

Authors:  Pramod Prahlad Chebbi; Ruchika Goel; J Ramya; M Gowri; ArianeL Herrick; Debashish Danda
Journal:  Rheumatol Int       Date:  2021-06-02       Impact factor: 3.580

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.